This study is looking at two different types of lipid (fat) infusions, called SOLE (soybean oil-based lipid emulsion) and MOLE (mixed oil lipid emulsion), to see which one is better for very premature babies. The goal is to find out if one of these infusions can help prevent bronchopulmonary dysplasia (BPD), a lung condition, and improve their overall health and development. Researchers will compare how well babies survive without BPD, their fatty acid levels, and signs of stress in their bodies. They will also look at how these infusions affect other health problems, long-term health, growth, and brain development at two years of age. You might be able to join if your baby was born very prematurely (under 28 weeks gestational age or weighing 1000g or less) and is between 12 hours and 28 weeks old. The study is currently unclear on its recruitment status.

Study design

This is an interventional study comparing two different lipid emulsions, SOLE and MOLE, in premature infants. It plans to enroll 230 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Researchers will assess participants for survival free of BPD at 36 weeks post menstrual age, and neurodevelopment at two years of age.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.